Prostate Cancer Screening in High-Risk Groups: Challenges to Equitable and Pragmatic Screening

Yaw A. Nyame, MD, MS, MBA, of Fred Hutchinson Cancer Center, describes the “high-risk” population in prostate cancer, how different natural history affects screening results and implications for early detection, the best PSA screening strategy to employ to positively affect screening rates, and what is needed to further Level 1 evidence for guideline statements and recommendations on screening for high-risk populations.

Dr. Nyame presented on prostate cancer screening in high-risk groups as part of a plenary session at the AUA 2024 Annual Meeting.